XCancer

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

Description:

This pilot phase I trial studies how well copper Cu 64 TP3805 positron emission tomography (PET) works in detecting prostate cancer in patients with persistently elevated prostate specific antigen (PSA). The copper Cu 64 TP3805 PET scan uses copper Cu 64 TP3805, a compound made of a radioactive agent attached to a molecule that looks like a hormone that binds to cancer cells to detect prostate cancer during PET scans. Copper Cu 64 TP3805 PET may be able to see tumors at an earlier stage than the standard of care.

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Phase:

N/A

Contacts:

Madhukar Thakur, PhD (PRINCIPAL_INVESTIGATOR)

Government Study Link:

NCT02989623 - Click here to see study on

ClinicalTrials.gov

TP3805

Isotope(s):
Target(s):
  • VPAC1
Ligand Class: Peptides
Chelator: N2S2
Inclusion
  • Persistently elevated PSA
  • Scheduled for magnetic resonance imaging (MRI) fusion/transrectal ultrasound (TRUS) biopsy, followed by histology
Exclusion

Exclusion Criteria Not Yet Provided